Oppenheimer Upgrades Ovid Therapeutics Inc (OVID) to Outperform
Tweet Send to a Friend
(Updated - January 29, 2025 9:54 AM EST)
Oppenheimer analyst Francois Brisebois upgraded Ovid Therapeutics Inc (NASDAQ: OVID) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Francois Brisebois upgraded Ovid Therapeutics Inc (NASDAQ: OVID) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
